Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

US Patent 7211671 · Granted May 1, 2007

Estimated economic value: $42,041,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,6,9-trisubstituted purines2025
Electronic test equipment and optional function configuring method2025
Amide-substituted heterocyclic compounds for the treatment of conditions related2025
Substituted indole and indazole compounds2024
Substituted indole dimer compounds2024
Opioid receptor ligands and methods of using and making same2024
Substituted indole compounds useful as TLR inhibitors2024
4-azaindole compounds2023
Substituted indole compounds2023
Substituted bicyclic compounds2023
Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 2023
Substituted indole compounds useful as inhibitors of TLR7/8/92022